On August 27, 2015, Xenetic Biosciences, Inc.'s CFO and director Colin Hill retired as member of its board of directors and as Chief Financial Officer. The agreement which was signed on August 27, 2015, was made effective by agreement of the parties as of July 31, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 USD | +4.28% | +0.03% | +13.04% |
May. 22 | Xenetic Biosciences, Inc. Announces Management Resignations | CI |
May. 22 | Xenetic Biosciences, Inc. Announces Chief Executive Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.04% | 5.76M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- XBIO Stock
- News Xenetic Biosciences, Inc.
- Xenetic Biosciences, Inc. Announces Retirement of Colin Hill as Member of its Board of Directors and as Chief Financial Officer